Introduction
Increasing obesity worldwide has been accompanied by an increase in dyslipidemia among children. Obesity and dyslipidemia are both related to the metabolic syndrome and are associated with the premature development of cardiovascular disease (CVD) .
1 It is therefore essential to identify pediatric dyslipidemia and to initiate measures to prevent, or at least slow, its development. Atherosclerosis is one of the leading causes of death in adulthood and there is evidence that it can begin in childhood and progress throughout life. For example, fatty streaks in the arterial wall have been observed in children, and these can progress in adulthood to form the atherosclerotic plaques responsible for arterial obstruction.
2 As well as genetic factors, lifestyle plays an important role in the progression of the disease, with unhealthy lifestyles and dietary habits promoting cardiovascular risk. 3 Recognized risk factors include dyslipidemia, obesity, hypertension, smoking, and diabetes. The early identification of these factors in childhood or adolescence can reduce the risk of CVD in adulthood.
Treating dyslipidemia can reduce low-density lipoprotein cholesterol (LDL-C) concentrations, improve endothelial function, substantially attenuate the progression of atherosclerosis, and ameliorate coronary outcomes.
total cholesterol (TC) and LDL-C concentrations above the 95th percentile for a child's age and sex, has been shown to be associated with the development of early CVD. Lipid concentrations in healthy children vary with age: at birth they are very low, increasing slowly during the first 2 years of life, and then stabilizing by adolescence. TC and LDL-C concentrations subsequently decrease by 10 to 20% or more during adolescence, before increasing again during late adolescence and young adulthood to similar levels as those prior to adolescence.
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Lipid disorders are defined according to population norms. The Lipid Research Clinics prevalence studies used population distributions to determine age-and sex-specific cutoff levels for TC and LDL-C concentrations. The National Heart, Lung, and Blood Institute (NHLBI) and the American Academy of Pediatrics have adopted the National Cholesterol Education Program's recommended cutoff values for defining dyslipidemia in children (TC ! 200 mg/dL and LDL-C ! 130 mg/dL). These levels are commonly used in published studies and have been widely accepted in clinical practice, where they are used as the basis for initiating dietetic and other measures 6 (►Table 1).
Types of Dyslipidemias
Dyslipidemias are classified as primary or secondary (►Table 2) according to different pathologies. In the latest, the treatment of the underlying disease is usually accompanied by improvement in, or resolution of, dyslipidemia. Genetic factors are involved in the etiology of primary forms of dyslipidemia.
7 They are classified as monogenic when only one gene involved in fat metabolism is altered or polygenic when several genes are involved (►Table 3). Monogenic primary dyslipidemias have the most severe pathologies and generally require pharmacological treatment because they are poorly modified by lifestyle and dietary changes.
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The most common type of genetically linked blood disorder is hypercholesterolemia, which, typically, is polygenic. It has been reported that plasma cholesterol levels are associated with nine single nucleotide polymorphisms located on nine different genes.
9 Polygenic hypercholesterolemia is associated not only with alterations of the genes involved in cholesterol metabolism, but also with obesity and unhealthy lifestyle behaviors, such as a poor diet and sedentary lifestyle.
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Multifactorial dyslipidemia is defined by elevated levels of LDL-C (>130 mg/dL) or TC (>200 mg/dL) that are not attributable to familial hypercholesterolemia. Several longitudinal studies have reported an association between childhood lipid levels in this range and indicators of atherosclerosis in adulthood. However, studies have shown that tracking lipid levels from childhood to adulthood cannot predict which individuals will have elevated LDL-C or TC as adults, although the tracking patterns of blood lipids from adolescence to adulthood are somewhat higher. Lifestyle changes, including improved diet and increased physical activity, are the first therapeutic measures to be initiated in children with this type of dyslipidemia. Dietary hygienic measures are essential and will sometimes be the only therapeutic interventions needed. However, in monogenic familial hypercholesterolemia, following the dietary recommendations alone is insufficient for achieving the intended therapeutic objective. 12 The decrease in LDL-C levels is closely related to the type of genetic mutation. However, it is indisputable that improving diet before commencing pharmacological treatment, or as an adjuvant to it, is essential when indicated.
11
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Selective Screening
Screening strategies for dyslipidemia in clinical practice are either selective or universal. Selective screening is based on a family history of dyslipidemia or premature CVD, whereas universal screening is based only on age. Universal screening is not indicated for children younger than 9 years because of a lack of conclusive studies that support its use. However, the most recent NHLBI expert recommendations advocate universal screening at ages 9 to 11 years, and again at ages 17 to 21 years, as well as selective screening at other ages because, to a greater or lesser extent, risk factors track from preadolescence and adolescence to adulthood.
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Treatment of Hypercholesterolemia in Children
The management of children with hypercholesterolemia focuses mainly on lowering blood cholesterol concentration and reducing other cardiovascular risk factors to prevent CVD. 15 Recommendations for healthy living habits should be the first goal. Healthy lifestyles and dietary habits that promote cardiovascular health are advocated, including dietary changes, increased physical activity, and eliminating the breathing of tobacco smoke. 16 For optimal compliance, the whole family should be involved. Obese children with hypercholesterolemia benefit from weight loss involving restriction of any excess energy intake. In general, fat contributes most to caloric excess, but food and drinks containing high levels of carbohydrates can be a major source of excess energy in overweight children who undertake very limited physical activity. Balancing energy intake and expenditure to maintain a healthy body weight is important; this includes controlling foods to avoid weight gain or assist with weight loss, maintaining adequate levels of physical activity, and minimizing the time spent in sedentary behaviors. Although data in children are limited, increased physical activity and a reduction in sedentary behavior may improve fasting lipid profiles and may even reduce the risk of CVD.
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Furthermore, there is strong evidence that increased physical activity has a positive influence on other cardiovascular risk factors, such as blood pressure and glucose levels. The NHBLI guidelines recommend moderate to vigorous activity for 1 hour/day, and taking part in a sport or activity that the child enjoys. For children aged 5 years and older, vigorous physical activity on at least 3 days per week is advised. In addition, total screen time, including the time spent watching television and playing videogames, should be restricted to 2 hours or less per day.
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Dietary Recommendations
The basis of the intervention for children with hypercholesterolemia is dietary modification. 19 Dietary interventions are not recommended to children younger than 2 years because, in this age group, limiting fat and calorie intake can cause nutritional deficiencies. Therefore, if there are risk factors, screening for childhood hypercholesterolemia is advisable between the age of 2 years and the start of puberty. Treatment should achieve a lasting decrease in cholesterol levels, thereby reducing the risk of premature cardiovascular morbidity and mortality. The diet should be as varied as possible to ensure the nutritional needs of the child are met while supporting a good quality of life and the child's enjoyment of eating. The caloric intake should be sufficient for growth and the level of physical activity undertaken should be appropriate for preventing the child becoming overweight.
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Effective dietary change requires continued counseling and practical training, and the child's family should be provided with rigorous information to enhance motivation. Dietary change is essential and should be part of a way to eat more healthily. The parents should be encouraged to adapt the recommendations to their personal and cultural preferences.
The aim of dietary treatment is to reduce plasma lipid concentrations from their initial levels. For children with a normal high-density lipoprotein cholesterol (HDL-C) level (>45 mg/dL), a targeted dietary modification is indicated when the LDL-C concentration exceeds 130 mg/dL. This should be supported by an initial dietetic approach that includes restricting total fat intake to 30% of the total daily calorie intake and saturated fat intake to <10%, and limiting the daily cholesterol intake to 300 mg or less. Polyunsaturated fatty acids should provide up to 10% of daily calories, and the target should be that monounsaturated fatty acids provide 10 to 15%. Trans fats should be avoided completely as they have been shown to increase LDL-C and reduce HDL-C.
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Because the diet will be maintained over a long period, assessment of nutritional status plays an important role in the follow-up of children with hypercholesterolemia.
Reduced Fat Intake
In most individuals, the total fat intake and, more importantly, the fatty acid composition of dietary fat affect plasma lipid and lipoprotein concentrations. 22 Dietary fatty acids differ in their effects on plasma lipids and lipoproteins because of differences in their chemical structure, especially whether the fatty acid chains include one or more double bonds between carbon atoms, and the locations of those bonds in the chain.
Reduced Percentage of Calories from Saturated Fat
Saturated fatty acids are those without any double bonds in the chain of carbon atoms. The dietary saturated long-chain fatty acids associated with the greatest increase in cholesterol levels are myristic acid from milk fat (with a chain length of 14 carbon atoms) and palmitic acid from palm oil (with a chain length of 16 carbon atoms). Both reduce LDL receptor activity, impair the rate of removal of LDL from circulation, and raise the plasma concentrations of TC, LDL-C, and, to some extent, HDL-C. 23 They should be restricted in any hypolipemic diet. Relatively short-chain fatty acids with 6 to 12 carbon atoms (such as caproic, caprylic, capric, and lauric acids) and stearic acid (with 18 carbon atoms), produce little or no change in plasma cholesterol concentrations. In general, reducing saturated fat intake lowers both LDL-C and HDL-C. Because the absolute effect tends to be greater for LDL-C than for HDL-C, reducing saturated fat intake has a beneficial effect on the lipid profile. Palmitic, myristic, lauric, and stearic saturated fatty acids are found in animal fats (such as those in butter, sausages, and cream) and in some vegetable oils, such as coconut and palm oil; these are widely used in the industrial manufacture of pastries and confectionery and to enrich or improve the taste of foods. 24 Foods with these saturated fatty acids have a high level of atherogenic effects and should be avoided. The current recommendation is to limit saturated fat intake initially to <10% of total energy intake.
Reduced Intake of Trans Fatty Acids
Trans fatty acids are unsaturated fatty acids where the double bond of unsaturation has been modified such that the adjacent carbon atoms have a trans arrangement, rather than the usual cis arrangement. The most commonly found trans fatty acid is elaidic acid. These acids have hypercholesterolemic effects, increasing LDL-C and reducing HDL-C concentrations, with some studies also reporting an increase in lipoprotein (a) concentration. 25 Reducing the intake of trans fatty acids therefore lowers LDL-C with little or no effect on HDL-C or triglyceride levels. Trans fatty acids are present in dairy fat and the meat from some ruminants due to the fermentation of intestinal microbiota. In addition, polyunsaturated fatty acids in some vegetable oils change their spatial arrangement when heated to a high temperature such as during frying or in the technological solidification processes used to convert vegetable oils from a liquid to a semisolid state through hydrogenation. Trans fatty acids have been used in foods to prevent oxidation and improve flavor. The recommendation is that trans fatty acid intake should not exceed 2% of total calories. 26 Adhering to the recommendation to reduce dietary sources of saturated fat (such as meat and dairy fat) will result in additional reductions in trans fatty acid intake.
Intake of Monounsaturated Fatty Acids
Monounsaturated fatty acids reduce TC and LDL-C concentrations while maintaining or increasing HDL-C. The main monounsaturated fatty acid is oleic acid, which is obtained from olive oil and nuts such as hazelnuts, almonds, and peanuts. Because of their greater resistance to oxidation, these oils are recommended for use in frying. However, the partial hydrogenation of oleic acid produces the trans fatty acid, elaidic acid, with the negative consequences described earlier. More recently, it has been shown that the replacement of saturated fatty acids with monounsaturated fatty acids has a hypocholesterolemic effect while minimizing the decrease in HDL-C concentration. 27 In addition, a diet rich in monounsaturated fatty acids compared with polyunsaturated fatty acids reduces susceptibility to the oxidative modification of plasma LDL-C. 28 The current recommendations suggest that monounsaturated fatty acids intake (such as rapeseed and olive oils) should form 10 to 15% of the total dietary energy intake.
Intake of Polyunsaturated Fatty Acids
Polyunsaturated fatty acids have two or more double bonds in the carbon chain. They are classified as omega-3 or omega-6 polyunsaturated fatty acids according to the position in the chain of the first double bond. In omega-3 fatty acids, the first double bond is at position 3 in the carbon chain. Linolenic acid is the precursor of the omega-3 series and is present in vegetable oils such as soybean, olive, and canola oils, and in some legumes. Linolenic acid derivatives include eicosapentaenoic and docosahexaenoic acids, which are found in the fat of blue fish such as tuna, salmon, mackerel, or sardine. They reduce triglyceride concentrations whereas LDL-C and HDL-C concentrations are either increased or unchanged. 29 In addition, they exhibit anti-inflammatory and antithrombotic effects. Conversely, several studies have shown small increases in lipoprotein oxidation or in plasma levels of lipid peroxides after taking fish oil supplements. 30 Because of this concern, consuming a large amount of dietary polyunsaturated fatty acids is not recommended because it could result in a lower plasma HDL-C concentration and may increase the oxidability of lipoproteins. In omega-6 fatty acids, the first double bond is at position 6 in the carbon chain. Linoleic acid, the precursor of the omega-6 series, is of vegetable origin and is present in the oil of some seeds, soybeans, sunflowers, corn, and nuts. It forms arachidonic acid, which is a precursor of prostaglandin E2 and leukotrienes, which exhibit an inflammatory effect and platelet aggregation action. 31 A diet rich in omega-6 fatty acids is associated with a decrease in HDL-C and LDL-C production. 32 These fatty acids are more susceptible to oxidation and are therefore more atherogenic than oleic acid. In consequence, it is recommended that the diet of hypercholesterolemic children should include only a moderate amount of polyunsaturated fatty acids (7-10% of total energy), mainly in the form of vegetable oils, such as corn and sunflower seed oils. In summary, the current recommendation for fat intake is to reduce the intake of saturated fat and replace it with unsaturated fats, especially monounsaturated fats, to reduce the risk of CVD. Common sources of saturated and unsaturated fats are summarized in ►Table 4.
Cholesterol
Because increased dietary cholesterol leads to increased plasma cholesterol and an increased risk for atherosclerosis, 33 the amount of dietary cholesterol should be restricted. Current recommendations restrict the intake of dietary cholesterol to 300 mg/day. Meeting this target requires the avoidance of foods that are naturally rich in cholesterol, including eggs, liver, kidneys, and seafood such as prawns. In general, foods rich in saturated fat are also rich in cholesterol.
Protein Quality
Protein should provide 10 to 8% of the total calorie intake, particularly proteins of high biological value from meat and fish, which provide essential amino acids. In addition to providing high-quality protein, milk and dairy products are also the main source of calcium, which has been reported to have cholesterol-lowering properties. 34 Dairy foods are complex, however, and recent evidence indicates that the dairy food matrix may be just as important as the individual components. 35 Furthermore, calcium from dairy products has been implicated in fecal fat excretion. The intake of vegetable proteins, especially those derived from legumes (such as soybeans and beans), produces better results than animal proteins in lowering cholesterol concentration, as observed in animal studies. 36 To avoid deficiency, the lack of methionine in legumes should be compensated for by combining legumes with foods that contain methionine, such as rice or potatoes.
Fibers
Dietary fiber consists of the endogenous components of plants that are resistant to digestion by the digestive enzymes. It is Dietary fiber supplementation may lower plasma TC and LDL-C concentrations. In particular, water-soluble non-cellulose pectin, gums and mucilages, and lignin may have specific lipid-lowering effects through increasing the excretion of bile salts. 37 The beneficial effects of dietary fiber for hypercholesterolemia and plasma lipids are extensive: the consumption of nuts rich in soluble fiber results in a decrease in LDL-C, and insoluble fiber is able to retain water and thus to increase the fecal bolus by regulating intestinal movements. The recommendation for dietary fiber is an intake of approximately 80% insoluble fiber and 20% soluble fiber. Foods rich in insoluble fiber include wheat bran, legumes, vegetables, cereals, and ripe fruit. Foods rich in soluble fiber include oats, carrots, and plums. It is advisable to ensure a diet rich in fiber by replacing refined cereals with whole-grain cereals and increasing the consumption of vegetables, fruit, and nuts. For children, the recommended daily intake of fiber in grams can be calculated as the child's age in years plus 5.
Plant Sterols and Stanols, and Other Supplements
Plant sterols (phytosterols) are molecules chemically similar to cholesterol, which are poorly absorbed. They are extracted from soybean oil and incorporated into some foods such as yogurt, milk, and margarines. They inhibit the absorption of dietary cholesterol and reduce endogenous cholesterol by competing with cholesterol in its aggregation with bile acids to form micelles; thus, some cholesterol will not be absorbed and will be eliminated in the feces.
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The efficacy of esters of plant sterols and stanols, when taken at or before meals, has been demonstrated, with large daily doses (2 g) resulting in a decrease of TC and LDL-C of 10 to 20%. Higher doses are not recommended, as they do not result in a greater effect but they may interfere with the absorption of fat-soluble vitamins. Ensuring an adequate fruit and vegetable intake can compensate for the potential reduction in the levels of these vitamins and carotenoids. Currently, the use of foods enriched with vegetable sterols/ stanols is not recommended for children under 6 years of age because of these nutritional concerns. 39 However, vegetable sterols may lower triglyceride levels through the decreased secretion of very LDL-C by the liver, although there is no evidence for this. Thus, vegetable sterols can improve the cardiovascular profile by their action on both LDL-C and triglycerides, with an excellent safety profile. 40 They can be used in schoolchildren and adolescents.
Other nutrients and supplements such as cereals enriched with psyllium, garlic extract, or canola oil have been evaluated only in small studies of children with high cholesterol; it is therefore not possible to make a firm recommendation about the use of any of these for children and adolescents.
Dietary Patterns
Different dietary patterns have been advocated to be useful in adults with hypercholesterolemia. The Mediterranean Diet comprises a high intake of fruit (particularly fresh fruit), vegetables (especially root and green varieties), whole grains (cereals, breads, rice, and pasta), and fatty fish (rich in omega-3 fatty acids). In addition, it involves a lower consumption of red meat (with an emphasis on lean meat), the substitution of higher-fat dairy foods with lower-fat or fatfree varieties, and the use of oils (olive or canola oil), nuts (walnuts, almonds, or hazelnuts), or spreads blended with rapeseed or flaxseed oils in place of butter and other fats. The Mediterranean Diet tends to include only a moderate level of total fat (32-35% of total calories) and is relatively low in saturated fats (9-10% of total calories), high in fiber, and high in polyunsaturated fatty acids (particularly omega-3). This dietary pattern is particularly recommended for hypercholesterolemic children. 
